DGAP-News: MorphoSys AG Reports First Quarter 2022 Financial

DGAP-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement MorphoSys AG Reports First Quarter 2022 Financial Results ...

Related Keywords

Germany , Boston , Massachusetts , United States , United Kingdom , Switzerland , Planegg , Bayern , Swiss , Jean Paul Kress , Xencor Inc , Linkedin , Twitter , Drug Administration , Nasdaq , Morphosys Group Key Figures , Development Rd Expenses , National Comprehensive Cancer Network , First Quarter , Clinical Practice Guidelines , Chief Executive Officer , Clinical Practice Guideline , National Comprehensive Cancer , B Cell Lymphomas , Preferred Regimen , Diffuse Largeb Cell Lymphoma , Net Loss , Financial Guidance , Sys Group Key Figures , Impairment Losses , Tax Benefit , Net Profit , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis ,